Arkolith/Insider Trading/VIRX/Form 4

Royston Ivor

CEO & President, DirectorViracta Therapeutics, Inc. (VIRX) · full profile →Form 4 · filed Aug 29, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$54K
Net Open-Market Flow
-$54K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2022Sell(S)13K$4.01$54K613K
Aug 25, 2022Option exercise(M)25K—$0626K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 25, 2022Option exercise(M)25K—$0277K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-047947) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML